GABAA agonist (positive allosteric modulator)

  • Panic disorder2
  • Anxiety (short-term)3
  • Insomnia (short-term)3
  • Akathisia2
  • Alcohol withdrawal1

Choosing a Benzo

Best Overall: Lorazepam: 0.5 to 3 mg/day divided q8-12 hr. PDR mentions can go up to 6 mg but that is rare (Side effects and withdrawal risks worse with high doses). It has few drug interactions or metabolites, a lower OD risk, and reasonable duration. Available as Loreev XR (brand only, but lowers misuse risk).

FDA-approved in Panic Disorder: Alprazolam (typical 2-5 mg/day), clonazepam (typical 1-2 mg/day).

Safest: Oxazepam (10-15 mg 3-4 times/day). This has lowest OD risk with opioids, and lowest risk of addiction when combined with stimulants (benzos should not be combined with stimulants, but if you inherit them, start by switching to oxazepam).

Lacking hepatic metabolism: Lorazepam, oxazepam, temazepam. These are ideal in elderly, hepatic impairment, and for avoiding drug interactions.

Best for alcohol withdrawal or benzo tapering: Diazepam and chlordiazepoxide preferable for their long half-lives, but if hepatic impairment use lorazepam. For benzo withdrawal, often best to use the same benzo they are on, especially with alprazolam.

Best for depression: Alprazolam speeds antidepressant meds up and treats core symptoms of depression, but should only be used short-term for that. Long-term use can cause depressive symptoms. The XR version is generic and has lower misuse risk.

Best for insomnia: Temazepam, lorazepam.

Least safe: Alprazolam, clonazepam, and diazepam have high risk of OD, misuse, diversion. Triazolam is notorious for causing disinhibition/aggression.

Safest in pregnancy. Avoid all benzos in pregnancy. Lorazepam is safest in breastfeeding.

Management

If using PRN for anxiety, tell patient to only take it if it improves their functioning and reduces avoidance (eg, don’t take it if you stay in bed all day).

Avoid in PTSD (worsens outcomes), borderline (rare disinhibition/aggression), delirium/dementia (worsens cognition), elderly, age < 18, taking opioids, antisocial personality.

Absolutely avoid in: History of benzo or opioid overdose. Elderly with history of falls or traffic accidents while on them (or high fall risk). Active substance misuse (especially opioids). Taking opioids with risk factors below.

Benzos-Opioids: When to Avoid the Combo to Minimize OD Risk
▪ ABSOLUTE CONTRAINDICATION
Active prescription misuse
Active addiction to benzos, opioids, alcohol, or other sedatives
History of sedative overdose (on sleep meds, benzos, opioids)
On opioid replacement therapy that you aren’t managing (let them manage both; OR risk is particularly high with methadone)
▪ STRONG RELATIVE CONTRAINDICATIONS
Daily opioid dose ≥ 50 morphine milligram equivalents (particularly with long-acting opioids and benzos)
Age ≥ 65
History of sedative, alcohol, or opioid use disorder (in remission)
Borderline or antisocial personality disorder or unstable psychiatric disorder with OD or suicide risk
Respiratory disease (eg COPD, sleep apnea), systemic medical illness (eg HIV, organ failure, renal or hepatic impairment), or pregnancy

Benzo Conversion

Conversion doses (based on clonazepam) are approximate. Use the lower end if patient is at high risk of adverse effects, the higher range if at high risk of withdraway/anxiety. The schedule does not always match the half-life because duration in the blood stream may not match duration in brain.

BenzodiazepineHalf LifeScheduleClonazepam 1mg =
Triazolam2-6 hrQHS0.5-1 mg
Oxazepam4-15 hrTID-QID60 mg
Temazepam8-22 hrQHS30-60 mg
Alprazolam6-12 hrBID-TID1-2 mg
Lorazepam10-20 hrBID-TID2-4 mg
Estazolam10-24 hrQHS2-4 mg
Clonazepam1-2 daysBID1 mg
Quazepam2-3 days +
1-6 days*
QHS30-40 mg
Diazepam1-4 days +
1-8 days*
BID-TID20 mg
Clorazepate< 30 min +
2-8 days*
BID-QID30 mg
Chlordiazepoxide½ – 2 days +
2-8 days*
BID-QID50 mg
Flurazepam2-3 hr +
2-10 days*
QHS30-60 mg

*These benzos have active metabolites that extend their action over longer half-lives.

Benzo Withdrawal

Lower the dose every 1-4 weeks. Lower faster and by larger amounts in the beginning, then slower and by smaller amounts toward end. Can switch to diazepam, which has a long half life and allows smaller increments in dose (it comes as 2 mg, which equals 0.1 mg of clonazepam). For other benzos, you can obtain smaller doses with liquid or microdosing (liquifying med).

Time on Daily BenzoTaper Duration
Less than 2 monthsTaper may not be required.
Reduce the benzo to “as needed” for 2-4 weeks, then stop
2-6 months2 to 3 weeks
6-12 months1-2 months
> 12 months2-4 months (or longer if high dose or long duration)

Below is a handout for patients, and Ashton guides for exact tapering doses.

EMR Text

Anxiety

Benzodiazepine use based on FDA approval in anxiety.

Benzodiazepine risks, including motoric, cognitive, sedation, tolerance/withdrawal, and respiraptory depression in combination with opioids, alcoho, and sedatives were reviewed with patient.

Insomnia

Benzodiazepine use based on FDA approval of this class for insomnia and favorable pharmacokinetic profile with this agent.

Benzodiazepine risks, including motoric, cognitive, sedation, tolerance/withdrawal, and respiraptory depression in combination with opioids, alcoho, and sedatives were reviewed with patient.

Akathisia

Benzodiazepine use based on clinical trials for akathisia (Bartels M et al, Pharmacopsychiatry. 1987;20(2):51-53).

Benzodiazepine risks, including motoric, cognitive, sedation, tolerance/withdrawal, and respiraptory depression in combination with opioids, alcoho, and sedatives were reviewed with patient.

Alcohol Withdrawal

Benzodiazepine use based FDA approval of this class in alcohol withdrawal. I have recommended inpatient treatment to manage withdrawal, but they decline this level of care and do not meet criteria for involuntary committment. The risk of untreated withdrawal (or continued alcohol use) outweigh the risks of outpatient management in this case, and we will minimize risks by dispensing in small amounts and monitoring for overuse.

Benzodiazepine risks, including motoric, cognitive, sedation, tolerance/withdrawal, and respiraptory depression in combination with opioids, alcoho, and sedatives were reviewed with patient.

Use with Opioids

I have reviewed risks of opioid-benzodiazepine combination and find the risks of untreated anxiety and benzodiazepine withdrawal outweigh the risks of with benzodiazepines in this case. Significant in this assessment is the patient’s history and a large study showing greater mortality risks with removal of a benzodiazepine compared to remaining on, even in patients at higher risk (eg older age, taking opioids) (Maust DT et al, JAMA Netw Open. 2023;6(12):e2348557).

Benzodiazepine risks, including motoric, cognitive, sedation, tolerance/withdrawal, and respiraptory depression in combination with opioids, alcoho, and sedatives were reviewed with patient.


Use this text to insert specific factors in their history that support the safety or efficacy, such as:

Protective factors include morphine milligram equivalents < 50; lack of history of sedative overdose; lack of history of falls; lack of systemic medical illness; age < 65; lack of history of substance use disorder.

To minimize risks with opioids, we will switch to a benzodiazepine with a lower overdose risk (lorazepam or oxazepam) and minimize dose. I will coordinate with clinician in charge of opioids and monitor use in the controlled substance database.

Patient has tried reasonable alternatives but responded uniquely to the benzodiazepine with demonstrable improvement in symptoms and functioning.

Scroll to Top